These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12521465)

  • 21. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E; Wildemeersch P
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):192-8. PubMed ID: 11848648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial.
    Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Yliskoski M; Vuorma S; Paavonen J
    BJOG; 2007 May; 114(5):563-8. PubMed ID: 17439564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceptability of the levonorgestrel intrauterine system in the long-term treatment of heavy menstrual bleeding: how many women choose to use a second device?
    Lete I; del Carme Cuesta M; Marín JM; Martínez M; Bermejo A; Arina R
    Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):67-70. PubMed ID: 20728261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)--a multicentre prospective study.
    Gemzell-Danielsson K; Inki P; Boubli L; O'Flynn M; Kunz M; Heikinheimo O
    Hum Reprod; 2010 Feb; 25(2):354-9. PubMed ID: 19955104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
    Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M
    Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compliance and user satisfaction with the intra-uterine contraceptive device in Family Planning Service: the results of a survey in Fife, Scotland, August 2004.
    Tewari R; Kay VJ
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):28-37. PubMed ID: 16546814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy during the use of levonorgestrel intrauterine system.
    Backman T; Rauramo I; Huhtala S; Koskenvuo M
    Am J Obstet Gynecol; 2004 Jan; 190(1):50-4. PubMed ID: 14749634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menstrual suppression with the levonorgestrel intrauterine system in girls with developmental delay.
    Hillard PJ
    J Pediatr Adolesc Gynecol; 2012 Oct; 25(5):308-13. PubMed ID: 22831901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids.
    Machado RB; de Souza IM; Beltrame A; Bernardes CR; Morimoto MS; Santana N
    Gynecol Endocrinol; 2013 May; 29(5):492-5. PubMed ID: 23461277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
    Li CF; Lee SS; Pun TC
    Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas.
    Bahamondes MV; Hidalgo MM; Bahamondes L; Monteiro I
    Contraception; 2011 Nov; 84(5):e11-6. PubMed ID: 22018132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
    Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
    Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
    Bahamondes L; Petta CA; Fernandes A; Monteiro I
    Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
    Andrade A; Wildemeersch D
    Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.